Dr. Paul Santos, PHARM.D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 548 Steele Hill Rd, Sanbornton, NH 03269 Phone: 603-527-2928 |
News Archive
Neuronix, which has developed an innovative medical device technology for the treatment of Alzheimer's Disease, announces today that it will present at the leading Alzheimer's Association International Conference, in Boston, United States.
"The growing threat of nodding disease and increased pressure for action has spurred the Ugandan government to announce a $3 million (USD) plan to address the mystery illness," Global Health Frontline News reports, adding, "Initial funds will be used to set up screening centers and treat those affected in Pader, Kitgum, and Lamwo districts in northern Uganda as early as this month."
A new study published in the Journal of Law and the Biosciences suggests that prohibiting anonymous sperm donation would result in a decline in the number of donors, and that those willing to donate would likely demand compensation for donation.
MabVax Therapeutics Holdings, Inc., a clinical-stage oncology drug-development company, announces receipt of notice from the U.S. Food and Drug Administration authorizing initiation of a Phase I clinical trial with 89Zr-HuMab-5B1 as a new generation PET scan cancer imaging agent in patients with pancreatic cancer.
The Gale and Graham Wright Prostate Centre at North York General Hospital is advancing prostate cancer care with a new study that shows the benefits of transperineal prostate biopsies under local anesthetic.
› Verified 4 days ago